Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance.

about

Magnetic resonance imaging: Physics basics for the cardiologist Osteoprotegerin and Myocardial Fibrosis in Patients with Aortic Stenosis

P2860

Q57721014-E40E7B5F-8BAA-4593-AB7C-D58AB69E25FB Q59126305-C57E26B5-A20D-4C13-91D2-F063DC197E5D

P2860

Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance.

Item

http://www.wikidata.org/entity/Q39555199

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Lipoprotein(a) in patients wit ...... iovascular magnetic resonance.

@en

type

Item

label

Lipoprotein(a) in patients wit ...... iovascular magnetic resonance.

@en

prefLabel

Lipoprotein(a) in patients wit ...... iovascular magnetic resonance.

@en

P1476

Lipoprotein(a) in patients wit ...... iovascular magnetic resonance.

@en

P2093

Aamir Ali

http://www.w3.org/2001/XMLSchema#string

Anita Sri

http://www.w3.org/2001/XMLSchema#string

Annina Studer Bruengger

http://www.w3.org/2001/XMLSchema#string

Brian Halliday

http://www.w3.org/2001/XMLSchema#string

Claire E Raphael

http://www.w3.org/2001/XMLSchema#string

Dominique Auger

http://www.w3.org/2001/XMLSchema#string

Helen Berry

http://www.w3.org/2001/XMLSchema#string

Jackie Donovan

http://www.w3.org/2001/XMLSchema#string

Nikhil Aggarwal

http://www.w3.org/2001/XMLSchema#string

Paul D Flynn

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

Lipoprotein(a) as a cardiovascular risk factor: current status

A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM

Plasma lipoproteins: teaching old dogmas new tricks

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Inhibition of fibrinolysis by lipoprotein(a).

Genetic associations with valvular calcification and aortic stenosis

Magnetic resonance imaging phantoms for quality-control of myocardial T1 and ECV mapping: specific formulation, long-term stability and variation with heart rate and temperature

P304

e0181077

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0181077

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dudley Pennell

Vassilios Vassiliou

P577

2017-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28704465

http://www.w3.org/2001/XMLSchema#string

P932

5509300

http://www.w3.org/2001/XMLSchema#string

Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance.

about

P2860

P2860

Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932